Mirabegron

Products Mirabegron is commercially available in the form of sustained-release film-coated tablets (Betmiga, USA: Myrbetriq). It was approved in the US and EU in 2012 and in many countries in 2014. Mirabegron was the first agent from the beta3 agonist group to be approved for the treatment of irritable bladder. It was originally intended to … Mirabegron

Docusate Sodium

Products Docusate sodium is commercially available in many countries in the form of soft capsules and as ear drops, among other products. It is not registered as a laxative in many countries. Structure and properties Docusate sodium (C20H37NaO7S, Mr = 444.6 g/mol) exists as white, hygroscopic, and waxy flakes or masses and is sparingly soluble … Docusate Sodium